Gianna Camiciottoli
- Pulmonary function and sputum characteristics predict computed tomography phenotype and severity of COPDBy Gianna Camiciottoli, Francesca Bigazzi, Matteo Paoletti, Lucia Cestelli, Federico Lavorini and Massimo PistolesiGianna CamiciottoliSection of Respiratory Medicine, Dept of Experimental and Clinical Medicine, University of Florence, Florence, ItalyFrancesca BigazziSection of Respiratory Medicine, Dept of Experimental and Clinical Medicine, University of Florence, Florence, ItalyMatteo PaolettiSection of Respiratory Medicine, Dept of Experimental and Clinical Medicine, University of Florence, Florence, ItalyLucia CestelliSection of Respiratory Medicine, Dept of Experimental and Clinical Medicine, University of Florence, Florence, ItalyFederico LavoriniSection of Respiratory Medicine, Dept of Experimental and Clinical Medicine, University of Florence, Florence, ItalyMassimo PistolesiSection of Respiratory Medicine, Dept of Experimental and Clinical Medicine, University of Florence, Florence, Italy
- Tracheo-bronchial collapsibility in different clinically determined COPD phenotypesBy Gianna Camiciottoli, Francesca Bigazzi, Stefano Diciotti, Simone Lombardo, Mario Mascalchi and Massimo PistolesiGianna Camiciottoli1Dept. of Internal Medicine, University of Florence, Florence, ItalyFrancesca Bigazzi1Dept. of Internal Medicine, University of Florence, Florence, ItalyStefano Diciotti2Dept. of Clinical Physiopathology, University of Florence, Florence, ItalySimone Lombardo2Dept. of Clinical Physiopathology, University of Florence, Florence, ItalyMario Mascalchi2Dept. of Clinical Physiopathology, University of Florence, Florence, ItalyMassimo Pistolesi1Dept. of Internal Medicine, University of Florence, Florence, Italy
- Pulmonary function and sputum characteristics predict CT phenotype and severity of COPDBy Gianna Camiciottoli, Francesca Bigazzi, Matteo Paoletti, Lucia Cestelli, Federico Lavorini and Massimo PistolesiArticle | Published in 2012 in European Respiratory JournalGianna Camiciottoli*Section of Respiratory Medicine, Dept of Experimental and Clinical Medicine, University of Florence, Florence, ItalyFrancesca Bigazzi*Section of Respiratory Medicine, Dept of Experimental and Clinical Medicine, University of Florence, Florence, ItalyMatteo Paoletti*Section of Respiratory Medicine, Dept of Experimental and Clinical Medicine, University of Florence, Florence, ItalyLucia Cestelli*Section of Respiratory Medicine, Dept of Experimental and Clinical Medicine, University of Florence, Florence, ItalyFederico Lavorini*Section of Respiratory Medicine, Dept of Experimental and Clinical Medicine, University of Florence, Florence, ItalyMassimo Pistolesi*Section of Respiratory Medicine, Dept of Experimental and Clinical Medicine, University of Florence, Florence, Italy
- Cardiovascular comorbidities prevails in the early stages of COPD irrespective of predominant airway or emphysema phenotypeBy Gianna Camiciottoli, Francesca Bigazzi, Valentina Luzzi, Elena Torricelli, Matteo Vannini, Alessio Garcea, Lorenzo Corsi, Matteo Paoletti, Lucia Cestelli and Massimo PistolesiGianna Camiciottoli1Clinical and Experimental Medicine, University of Florence, Florence, ItalyFrancesca Bigazzi1Clinical and Experimental Medicine, University of Florence, Florence, ItalyValentina Luzzi1Clinical and Experimental Medicine, University of Florence, Florence, ItalyElena Torricelli1Clinical and Experimental Medicine, University of Florence, Florence, ItalyMatteo Vannini1Clinical and Experimental Medicine, University of Florence, Florence, ItalyAlessio Garcea1Clinical and Experimental Medicine, University of Florence, Florence, ItalyLorenzo Corsi1Clinical and Experimental Medicine, University of Florence, Florence, ItalyMatteo Paoletti1Clinical and Experimental Medicine, University of Florence, Florence, ItalyLucia Cestelli1Clinical and Experimental Medicine, University of Florence, Florence, ItalyMassimo Pistolesi1Clinical and Experimental Medicine, University of Florence, Florence, Italy
- Frequency and severity of exacerbations reflect COPD severity, but not COPD phenotype as determined by quantitative CTBy Francesca Bigazzi, Alessio Garcea, Matteo Vannini, Elena Torricelli, Valentina Luzzi, Matteo Paoletti, Stefano Diciotti, Gianna Camiciottoli and Massimo PistolesiFrancesca Bigazzi1Department of Experimental and Clinical Medicine, University of Florence, Florence, ItalyAlessio Garcea1Department of Experimental and Clinical Medicine, University of Florence, Florence, ItalyMatteo Vannini1Department of Experimental and Clinical Medicine, University of Florence, Florence, ItalyElena Torricelli1Department of Experimental and Clinical Medicine, University of Florence, Florence, ItalyValentina Luzzi1Department of Experimental and Clinical Medicine, University of Florence, Florence, ItalyMatteo Paoletti1Department of Experimental and Clinical Medicine, University of Florence, Florence, ItalyStefano Diciotti2Department of Engineering, University of Bologna, Bologna, ItalyGianna Camiciottoli1Department of Experimental and Clinical Medicine, University of Florence, Florence, ItalyMassimo Pistolesi1Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy
- Interstitial lung disease in systemic sclerosis: where do we stand?By Susanna Cappelli, Silvia Bellando Randone, Gianna Camiciottoli, Amato De Paulis, Serena Guiducci and Marco Matucci-CerinicSusanna Cappelli1Dept of Experimental and Clinical Medicine, Division of Rheumatology AOUC, School of Medicine, University of Florence, Florence, ItalySilvia Bellando Randone1Dept of Experimental and Clinical Medicine, Division of Rheumatology AOUC, School of Medicine, University of Florence, Florence, ItalyGianna Camiciottoli2Dept of Experimental and Clinical Medicine, Division of Pneumology and Lung Physiopathology AOUC, School of Medicine, University of Florence, Florence, ItalyAmato De Paulis3Dept of Translational Medical Sciences and Center for Basic and Clinical Immunology Research (CISI), University of Naples Federico II, Naples, ItalySerena Guiducci1Dept of Experimental and Clinical Medicine, Division of Rheumatology AOUC, School of Medicine, University of Florence, Florence, ItalyMarco Matucci-Cerinic1Dept of Experimental and Clinical Medicine, Division of Rheumatology AOUC, School of Medicine, University of Florence, Florence, Italy
- Can we consider the “frequent exacerbator” a reliable COPD phenotype?By Francesca Bigazzi, Alessio Garcea, Elena Torricelli, Viola Bonti, Matteo Paoletti, Gianna Camiciottoli and Massimo PistolesiFrancesca BigazziDepartment of Experimental and Clinical Medicine, University of Florence, Florence, ItalyAlessio GarceaDepartment of Experimental and Clinical Medicine, University of Florence, Florence, ItalyElena TorricelliDepartment of Experimental and Clinical Medicine, University of Florence, Florence, ItalyViola BontiDepartment of Experimental and Clinical Medicine, University of Florence, Florence, ItalyMatteo PaolettiDepartment of Experimental and Clinical Medicine, University of Florence, Florence, ItalyGianna CamiciottoliDepartment of Experimental and Clinical Medicine, University of Florence, Florence, ItalyMassimo PistolesiDepartment of Experimental and Clinical Medicine, University of Florence, Florence, Italy
Buying books on this site
Purchases made on this website are of electronic books only.
About the ERS books
The ERS Monograph is the quarterly book series from the European Respiratory Society. Each Monograph covers a specific area of respiratory medicine, providing in-depth reviews that give clinicians at all levels a concise, comprehensive guide to symptoms, diagnosis and treatment.
The ERS Handbooks are compact guides to broad areas of the respiratory field. Launched in 2010, the series now covers adult, paediatric and sleep respiratory medicine, includes a companion volume of self-assessment questions and features the ERS Practical Handbooks.
